Cargando…

Are the Immunohistochemistry-Based Biomarkers Helpful for Predicting Prognosis in Patients with Surgically Resected Cholangiocarcinoma?

Detalles Bibliográficos
Autor principal:	Kim, Dong Uk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of Gut and Liver 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840913/ https://www.ncbi.nlm.nih.gov/pubmed/36636886 http://dx.doi.org/10.5009/gnl220542

Ejemplares similares

Patients' prognosis of intrahepatic cholangiocarcinoma and combined hepatocellular‐cholangiocarcinoma after resection
por: Song, Peipei, et al.
Publicado: (2019)

Survival benefits of surgical resection in recurrent cholangiocarcinoma
por: Song, Sun Choon, et al.
Publicado: (2011)

Awakening of SCHLAFEN 11 by immunohistochemistry: a new biomarker predicting response to chemotherapy
por: Buettner, Reinhard
Publicado: (2021)

Predicting Prognosis and Platinum Resistance in Ovarian Cancer: Role of Immunohistochemistry Biomarkers
por: Atallah, Ghofraan Abdulsalam, et al.
Publicado: (2023)

Comparison of the clinical results of surgical resection for extrahepatic cholangiocarcinomas: Hilar cholangiocarcinoma and mid-to-distal cholangiocarcinoma
por: Jung, Pyung, et al.
Publicado: (2019)

Changing Perspectives in the Assessment of Resectability of Hilar Cholangiocarcinoma
por: van Gulik, Thomas M., et al.
Publicado: (2007)

Identification of macrophage correlated biomarkers to predict the prognosis in patients with intrahepatic cholangiocarcinoma
por: Xu, Linping, et al.
Publicado: (2022)

Characterization of the Estrogen Response Helps to Predict Prognosis and Identify Potential Therapeutic Targets in Cholangiocarcinoma
por: Lu, Chenglin, et al.
Publicado: (2022)

Is Neoadjuvant Therapy Needed in Patients with Resectable Pancreatic Cancer?
por: Kim, Dong Uk
Publicado: (2022)

An Inflammation-Index Signature Predicts Prognosis of Patients with Intrahepatic Cholangiocarcinoma After Curative Resection
por: He, Chaobin, et al.
Publicado: (2021)

Nomograms for predicting overall survival and cancer-specific survival in patients with surgically resected intrahepatic cholangiocarcinoma
por: Ma, Kexin, et al.
Publicado: (2019)

Role of autophagy-related protein in the prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgical resection
por: Perng, Daw-Shyong, et al.
Publicado: (2021)

Pushing the limits for the surgical treatment of intrahepatic cholangiocarcinoma
por: Choi, Woo Jin, et al.
Publicado: (2023)

Surgical Management of Intrahepatic Cholangiocarcinoma: Quo Vadis
por: Moris, Dimitrios
Publicado: (2023)

Using immunovascular characteristics to predict very early recurrence and prognosis of resectable intrahepatic cholangiocarcinoma
por: Xu, Ying, et al.
Publicado: (2023)

Active Autophagy Is Associated with Favorable Outcome in Patients with Surgically Resected Cholangiocarcinoma
por: Bankov, Katrin, et al.
Publicado: (2023)

Biomarkers for predicting the prognosis of intrahepatic cholangiocarcinoma: A retrospective single-center study
por: Li, Xueliang, et al.
Publicado: (2023)

Effect of hepatic artery resection and reconstruction on the prognosis of patients with advanced hilar cholangiocarcinoma
por: Li, Yuan-Ming, et al.
Publicado: (2022)

High expression of Oct4 and Nanog predict poor prognosis in intrahepatic cholangiocarcinoma patients after curative resection
por: Zhang, Mei-xia, et al.
Publicado: (2019)

Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma
por: He, Chaobin, et al.
Publicado: (2018)

Hilar cholangiocarcinoma: Controversies on the extent of surgical resection aiming at cure
por: Xiang, Shuai, et al.
Publicado: (2014)

Surgical Resection and Prognostic Analysis of 142 Cases of Hilar Cholangiocarcinoma
por: Yu, Zhimin, et al.
Publicado: (2017)

The Role of Surgical Resection and Liver Transplantation for the Treatment of Intrahepatic Cholangiocarcinoma
por: Panayotova, Guergana, et al.
Publicado: (2021)

Novel Preoperative Nomogram for Prediction of Futile Resection in Patients Undergoing Exploration for Potentially Resectable Intrahepatic Cholangiocarcinoma
por: Nam, Kwangwoo, et al.
Publicado: (2017)

Multiplex immunohistochemistry/immunofluorescence is superior to tumor mutational burden and PD‐L1 immunohistochemistry for predicting response to anti‐PD‐1/PD‐L1 immunotherapy
por: Hu, Weixian
Publicado: (2019)

Surgical management of carcinoma in situ at ductal resection margins in patients with extrahepatic cholangiocarcinoma
por: Wakai, Toshifumi, et al.
Publicado: (2018)

Body composition is associated with disease aetiology and prognosis in patients undergoing resection of intrahepatic cholangiocarcinoma
por: Lurje, Isabella, et al.
Publicado: (2023)

Positive expression of Midkine predicts early recurrence and poor prognosis of initially resectable combined hepatocellular cholangiocarcinoma
por: Ma, Ming-Chun, et al.
Publicado: (2018)

Peritumoral plasmacytoid dendritic cells predict a poor prognosis for intrahepatic cholangiocarcinoma after curative resection
por: Hu, Zhi-Qiang, et al.
Publicado: (2020)

Development and validation of a gradient boosting machine to predict prognosis after liver resection for intrahepatic cholangiocarcinoma
por: Ji, Gu-Wei, et al.
Publicado: (2022)

Clinicopathological Significance of Syndecan-1 in Cholangiocarcinoma: A Study Based on Immunohistochemistry and Public Sequencing Data
por: Gerber, Tiemo S., et al.
Publicado: (2021)

The promise of precision medicine: how biomarkers are shaping the future of cholangiocarcinoma treatment
por: Macias, Rocio I. R., et al.
Publicado: (2023)

Predictors for the development of cholangiocarcinoma and hepatocellular carcinoma: in search for the most accurate biomarker
por: Tzovaras, Alexandros A., et al.
Publicado: (2011)

Standardization of PD-L1 immunohistochemistry
por: Martinez-Morilla, Sandra, et al.
Publicado: (2021)

Pneumonia Associated with 2019 Novel Coronavirus: Can Computed Tomographic Findings Help Predict the Prognosis of the Disease?
por: Lee, Kyung Soo
Publicado: (2020)

Resection of Hilar Cholangiocarcinoma
por: Strasberg, Steven M.
Publicado: (1998)

Clustering of patients with intrahepatic cholangiocarcinoma based on serum periostin may be predictive of prognosis
por: Thuwajit, Chanitra, et al.
Publicado: (2017)

Visible-absorption spectroscopy as a biomarker to predict treatment response and prognosis of surgically resected esophageal cancer
por: Yang, Pei-Wen, et al.
Publicado: (2016)

A novel prognostic nomogram for patients with surgically resected perihilar cholangiocarcinoma: a SEER-based study
por: Li, Pengfei, et al.
Publicado: (2021)

Effect of lymph node resection on prognosis of resectable intrahepatic cholangiocarcinoma: A systematic review and meta-analysis
por: Li, Feiyu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q44dee541gg8dba9et00b3ssrp